Na+/H+ exchange hyperactivity and myocardial hypertrophy: are they linked phenomena?
Cingolani
H E
HE
D000804:Angiotensin II / Q000378:metabolism; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology; D017920:Antiporters / Q000378:metabolism; D006332:Cardiomegaly / Q000378:metabolism*; D004912:Erythrocytes / Q000378:metabolism; D006801:Humans; D006863:Hydrogen-Ion Concentration; D006973:Hypertension / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects; D017923:Sodium-Hydrogen Exchangers / Q000378:metabolism*
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D017920:Antiporters; D017923:Sodium-Hydrogen Exchangers; C045885:sodium-lithium countertransporter; D000804:Angiotensin II